NCT07132918View on ClinicalTrials.gov

HEARTS Trial for Thoracic Cancers

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 8, 2025

Primary Completion Date

March 31, 2029

Study Completion Date

March 31, 2029

Conditions
Non-Small Cell Lung Cancer (Stage III)Esophageal Cancer Stage I-IIIEsophagogastric Cancer Stage I-IIIThymoma and Thymic Carcinoma Stage II-IIIOther Cancers in the Thoracic Region
Interventions
RADIATION

MRgART

Magnetic Resonance-guided Adaptive Radiation Therapy (MRgART) is a form of MRgRT that incorporates daily adaptive planning, or making a new treatment plan each treatment, and real-time imaging during treatment delivery.

RADIATION

LINAC

Daily 3D x-ray scans will be obtained for radiation delivery to confirm tumor and organ at risk placement.

Trial Locations (1)

53705

RECRUITING

University of Wisconsin - Madison, Madison

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Wisconsin, Madison

OTHER